NEW YORK (GenomeWeb) – The GenomeWeb Index fell 0.5 percent in June as stocks and indices fell on fears of what will happen now that the UK has voted to leave the European Union.

The Index underperformed the Dow Jones Industrial Average, which was able to rally after significant losses in the last week of June to gain 0.8 percent overall during the month. However, the GWDN Index outperformed both the Nasdaq and the Nasdaq Biotechnology Index, which lost 2 percent and nearly 8 percent in June, respectively.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.